Cargando…
Malignant Hyperthermia Syndrome: A Clinical Case Report
Malignant hyperthermia is a pharmacogenetic disorder. It manifests as a hypercatabolic skeletal muscle syndrome linked to inhaled volatile anesthetics or depolarizing muscle relaxants. Its clinical signs and symptoms are tachycardia, hyperthermia, hypercapnia, acidosis, muscle rigidity, rhabdomyolys...
Autores principales: | Acosta, Isabel Sánchez-Molina, de Cos, Guillermo Velasco, Fernández, Matilde Toval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343040/ https://www.ncbi.nlm.nih.gov/pubmed/34421497 |
Ejemplares similares
-
Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i
por: Velasco de Cos, Guillermo, et al.
Publicado: (2021) -
Case Report of Malignant Hyperthermia in the Emergency Department
por: McMurray, Mitchell, et al.
Publicado: (2023) -
Malignant hyperthermia-like syndrome in acute chlorfenapyr poisoning – A case report
por: Zhang, Shuyi, et al.
Publicado: (2022) -
Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
por: Velasco de Cos, Guillermo, et al.
Publicado: (2021) -
Malignant hyperthermia in severe COVID-19: 2 case reports
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2021)